Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3 (original) (raw)

• Makino S, Kunimoto K, Muraoka Y et al. (1980) Breeding of a non-obese diabetic strain of mice. Exp Anim 29: 1–13
  Google Scholar
• Castano L, Eisenbarth G (1990) Type I diabetes. A chronic autoimmune disease of humans, mouse and rat. Annu Rev Immunol 8: 647–679
  Article PubMed Google Scholar
• Lampeter F, Signore A, Gale E, Pozzilli P (1989) Lessons from the NOD mouse for the pathogenesis and immunotherapy of human type I (insulin-dependent) diabetes mellitus. Diabetologia. 32: 703–708
  Article PubMed Google Scholar
• Rossini AA, Greiner DL, Friedman HP, Mordes JP (1993) Immunopathogenesis of diabetes mellitus. Diabetes Rev 1(1): 43–75
  Google Scholar
• Hewison M (1992) Vitamin D and the immune system. J Endocrinol 132: 173–175
  PubMed Google Scholar
• Rigby WFC (1988) The immunobiology of vitamin D. Immunol Today 9: 54–58
  Article PubMed Google Scholar
• Provvedini DM, Manolagas SC, Deftos LJ (1983) 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science 221: 1181–1183
  PubMed Google Scholar
• Provvedini DM, Manolagas SC (1989) 1,25 dihydroxyvitamin D3 receptor distribution and effects in subpopulations of normal human T lymphocytes. J Clin Endocrinol Metab 68: 774–779
  PubMed Google Scholar
• Bhalla A, Amento E, Serog B, Glimcher L (1984) 1,25-Dihydroxy-vitamin D3 inhibits antigen-induced T cells activation. J Immunol 133: 1748–1755
  PubMed Google Scholar
• Rigby WFC, Denome S, Fanger NW (1987) Regulation of lymphokine production and human T lymphocyte activation by 1,25 dihydroxy-vitamin D3. J Clin Invest 79: 1659–1664
  PubMed Google Scholar
• Rigby WFC, Yirinec B, Oldershaw RL, Fanger MW (1987) Comparison of the effects of 1,25 dihydroxyvitamin D3 on T lymphocyte subpopulations. Eur J Immunol 17: 563–566
  PubMed Google Scholar
• Reichel H, Koeffler HP, Tobler A, Norman AW (1987) 1α, 25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci USA 84: 3385–3391
  PubMed Google Scholar
• Saggese G, Federico G, Balestri M, Torriolo A (1989) Calcitriol inhibits the PHA-induced production of IL-2 and IFN-gamma and the proliferation of human peripheral blood leukocytes while enhancing the surface expression of HLA class II molecules. J Endocrinol Invest 12: 329–335
  PubMed Google Scholar
• Meehan MA, Kerman RH, Lemire JM (1992) 1,25-Dihydroxyvitamin D3 enhances the generation of non specific suppressor cells while inhibiting the induction of cytotoxic cells in a human MLR. Cell Immunol 140: 400–409
  PubMed Google Scholar
• Lemire JM (1992) Immunomodulatory role of 1,25-dihydroxyvitamin D3. J Cell Biochem 49: 26–31
  PubMed Google Scholar
• Rigby WFC, Waugh MG (1992) Decreased accessory cell function and costimulatory activity by 1,25-dihydroxyvitamin D3-treated monocytes. Arthritis Rheum 35: 110–119
  PubMed Google Scholar
• Fournier C, Gepner P, Sadouk M, Charriere J (1990) In vivo beneficial effects of cyclosporin A and 1,25-dihydroxyvitamin D3 on the induction of experimental autoimmune thyroiditis. Clin Immunol Immunopathol 54: 53–63
  Article PubMed Google Scholar
• Lemire J, Archer C (1991) 1,25-Dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest 87: 1103–1107
  PubMed Google Scholar
• Mathieu C, Laureys J, Sobis H, Vandeputte M, Waer M, Bouillon R (1992) 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes 41(11): 1491–1495
  PubMed Google Scholar
• Verhaeghe J, Bouillon R, Lissens W, Visser WJ, Van Assche FA (1988) Diabetes and low Ca-P diet have opposite effects on adult and fetal bone mineral metabolism. Am J Physiol 254: E496-E504
  PubMed Google Scholar
• Serreze DV, Leiter EH (1988) Defective activation of T suppressor cell function in nonobese diabetic mice. J Immunol 140(11): 3801–3807
  PubMed Google Scholar
• Kataoka S, Satoh J, Fujiya H et al. (1983) Immunological aspects of the nonobese diabetic (NOD) mouse. Abnormalities of cellular immunity. Diabetes 32: 247–253
  PubMed Google Scholar
• Zipris D, Lazarus AH, Crow AR, Hadzija M, Delovitch TL (1991) Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. J Immunol 146: 3763–3771
  PubMed Google Scholar
• Harrada M, Makino S (1986) Suppression of overt diabetes in NOD mice by anti-thymocyte serum or anti-Thy 1.2 antibody. Exp Anim 35: 501–504
  Google Scholar
• Koike T, Itoh Y, Ishii T et al. (1987) Preventive effect of monoclonal anti-L3T4 antibody on the development of diabetes in NOD mice. Diabetes 36: 539–541
  PubMed Google Scholar
• Mori Y, Suko M, Okudaira H et al. (1986) Preventive effects of cyclosporine on diabetes in NOD mice. Diabetologia 29: 244–247
  PubMed Google Scholar
• Miyagawa J, Yamamoto K, Hanafusa T et al. (1990) Preventive effect of a new immunosuppressant FK-506 on insulitis and diabetes in non-obese diabetic mice. Diabetologia 33: 503–505
  PubMed Google Scholar
• Serreze DV, Hamaguchi K, Leiter EH (1989) Immunostimulation circumvents diabetes in NOD/Lt mice. J Autoimmunity 2: 759–776
  Article Google Scholar
• Manolagas SC, Hustmeyer FG, Yu XP (1990) Immunomodulating properties of 1,25-dihydroxyvitamin D3. Kidney Int 38 [Suppl 29]: S9-S16
  Google Scholar
• Walters MR (1992) Newly identified actions of the vitamin D endocrine system. Endocrine Res 13: 719–764
  Article Google Scholar
• Bikle DD (1992) Clinical counterpart: vitamin D: new actions, new analogs, new therapeutic potential. Endocrine Res 13: 765–784
  Article Google Scholar
• Hess AD, Donnenberg AD, Tutschka PJ, Santos G (1983) Effects of cyclosporin A on human lymphocyte response in vitro. J Immunol 130(2): 717–721
  PubMed Google Scholar
• Zarrabeitia MT, Riancho JA, Amado JA, Olmos JM, Gonzalez-Macias J (1992) Effect of calcitriol on the secretion of prostaglandin E2, IL-1 and tumor necrosis factor alpha by human monocytes. Bone 13(2): 185–189
  Article PubMed Google Scholar
• Hutchings PR, Cooke A (1990) The transfer of autoimmune diabetes in NOD mice can be inhibited or accelerated by distinct cell populations present in normal splenocytes taken from young males. J Autoimmunity 3: 175–185
  Article Google Scholar
• Boitard C, Yasunami R, Dardenne M, Bach JF (1989) T cell mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J Exp Med 169: 1669–1680
  Article PubMed Google Scholar
• Binderup L, Bramm E (1988) Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem Pharmacol 37: 889–895
  Article PubMed Google Scholar
• Bouillon R, Allewaert K, Xiang DZ, Tan BK, Van Baelen H (1991) Vitamin D analogs with low affinity for the vitamin D binding protein: enhanced in vitro and decreased in vivo activity. J Bone Mineral Res 6: 1051–1057
  Google Scholar
• Binderup L, Latini S, Kissmeyer AM (1991) New vitamin D3 analogues with potent effects on cell growth regulation and immune responses: structure-activity studies. In: A. W. Norman, R. Bouillon, M. Thomasset (eds) Vitamin D. Gene regulation, structure-function analysis and clinical application. De Gruyter, Berlin, pp. 478–485
  Google Scholar
• Latini S, Binderup L (1991) KH1060. A new vitamin D analogue with potent effects on cell-mediated immune responses in vitro. In: A. W. Norman, R. Bouillon, M. Thomasset (eds) Vitamin D. Gene regulation, structure-function analyses and clinical application. De Gruyter, Berlin, pp. 516–519
  Google Scholar
• Abe J, Nakamura K, Takita Y, Nakano T, Irie H, Nishii Y (1990) Prevention of immunological disorders in MRL/I mice by a new synthetic analogue of vitamin D3: 22oxa-1α,25-Dihydroxyvitamin D3. J Nutr Sci Vitaminol 36: 21–31
  PubMed Google Scholar